{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:00:33Z","timestamp":1790125233643,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52473119"],"award-info":[{"award-number":["52473119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470567"],"award-info":[{"award-number":["82470567"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070550"],"award-info":[{"award-number":["82070550"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["L2612014"],"award-info":[{"award-number":["L2612014"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Staphylococcal bacteria, particularly methicillin-resistant\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    (MRSA), are responsible for intractable infections\u2014especially those associated with implants\u2014through biofilm formation, presenting a worldwide menace. Antibacterial enzymes like lysostaphin (Lst) are promising for combating staphylococcal infections but limited by poor stability, high immunogenicity, and suboptimal pharmacokinetics, which hamper their clinical translation as antibiotic alternatives. Herein, we report a strategy of fusing thermosensitive elastin-like polypeptides (ELPs) to Lst to overcome these inherent drawbacks and eradicate MRSA biofilm-induced implant infections. Guided by AlphaFold2, we rationally engineered a chimeric Lst-ELP fusion protein that preserves potent lytic activity, demonstrates markedly enhanced stability, and exhibits substantially reduced immunogenicity relative to free Lst. The thermosensitivity of Lst-ELP enables in situ formation of a sustained-release depot upon subcutaneous injection, translating to an increased maximum tolerated dose, improved pharmacokinetics, and optimized biodistribution. Consequently, a single injection of Lst-ELP not only fully eradicated MRSA biofilms on implants and MRSA from the bloodstream and wound tissues, but also eliminated local and systemic inflammatory responses. This approach achieved complete clearance of MRSA biofilm-associated implant infections without adverse effects, highlighting its potential for clinical translation.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-76664-4","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:04:12Z","timestamp":1786705452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eradication of MRSA biofilm-associated implant infections by low-immunogenic sustained-release lysostaphin fused to thermosensitive polypeptides"],"prefix":"10.1038","volume":"17","author":[{"given":"Guoqing","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Like","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1555-9985","authenticated-orcid":false,"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengmin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5651-4890","authenticated-orcid":false,"given":"Wanliang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2795-8943","authenticated-orcid":false,"given":"Shengtao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-3044","authenticated-orcid":false,"given":"Weiping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"76664_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2642","volume":"9","author":"HF Chambers","year":"2009","unstructured":"Chambers, H. F. & Deleo, F. R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 9, 629\u2013641 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"76664_CR2","doi-asserted-by":"publisher","first-page":"18033","DOI":"10.1038\/nrdp.2018.33","volume":"4","author":"AS Lee","year":"2018","unstructured":"Lee, A. S., Otto, M., Ong, D. S. Y., Takeuchi, K. A. & See, W. D. C. Methicillin-resistant Staphylococcus aureus. Nat. Rev. Dis. Prim. 4, 18033 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"76664_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","volume":"4","author":"NA Turner","year":"2019","unstructured":"Turner, N. A. et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat. Rev. Microbiol. 4, 203\u2013218 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"76664_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41579-025-01226-2","volume":"24","author":"JB Parsons","year":"2026","unstructured":"Parsons, J. B., Mourad, A., Conlon, B. P., Kielian, T. & Fowler, V. G. Jr Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment. Nat. Rev. Microbiol. 24, 397\u2013409 (2026).","journal-title":"Nat. Rev. Microbiol."},{"key":"76664_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41579-018-0019-y","volume":"16","author":"CR Arciola","year":"2018","unstructured":"Arciola, C. R., Campoccia, D. & Montanaro, L. Implant infections: adhesion, biofilm formation and immune evasion. Nat. Rev. Microbiol. 16, 397\u2013409 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"76664_CR6","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","volume":"13","author":"SS Magill","year":"2014","unstructured":"Magill, S. S. et al. Multistate point-prevalence survey of health care-associated infections. N. Engl. J. Med. 13, 1198\u20131208 (2014).","journal-title":"N. Engl. J. Med."},{"key":"76664_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrmicro2415","volume":"9","author":"HC Flemming","year":"2010","unstructured":"Flemming, H. C. & Wingender, J. The biofilm matrix. Nat. Rev. Microbiol. 9, 623\u2013633 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"76664_CR8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/nrmicro.2017.99","volume":"12","author":"H Koo","year":"2017","unstructured":"Koo, H., Allan, R. N., Howlin, R. P., Stoodley, P. & Hall-Stoodley, L. Targeting microbial biofilms: current and prospective therapeutic strategies. Nat. Rev. Microbiol. 12, 740\u2013755 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"76664_CR9","doi-asserted-by":"crossref","unstructured":"Darouiche, R. O. Treatment of infections associated with surgical implants. N. Engl. J. Med. 350, 1422\u20131429 (2004).","DOI":"10.1056\/NEJMra035415"},{"key":"76664_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","volume":"9276","author":"PS Stewart","year":"2001","unstructured":"Stewart, P. S. & Costerton, J. W. Antibiotic resistance of bacteria in biofilms. Lancet 9276, 135\u2013138 (2001).","journal-title":"Lancet"},{"key":"76664_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0140-6736(03)12489-0","volume":"9356","author":"F Guarner","year":"2003","unstructured":"Guarner, F. & Malagelada, J. R. Gut flora in health and disease. Lancet 9356, 512\u2013519 (2003).","journal-title":"Lancet"},{"key":"76664_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/s41579-020-0385-0","volume":"10","author":"KP Rumbaugh","year":"2020","unstructured":"Rumbaugh, K. P. & Sauer, K. Biofilm dispersion. Nat. Rev. Microbiol. 10, 571\u2013586 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"76664_CR13","doi-asserted-by":"crossref","unstructured":"Schindler, C. A. & Schuhardt, V. T. Lysostaphin: a new bacteriolytic agent for the Staphylococcus. Proc. Natl. Acad. Sci. USA 51, 414\u2013421 (1964).","DOI":"10.1073\/pnas.51.3.414"},{"key":"76664_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00253-008-1579-y","volume":"80","author":"JK Kumar","year":"2008","unstructured":"Kumar, J. K. Lysostaphin: an antistaphylococcal agent. Appl. Microbiol. Biotechnol. 80, 555\u2013561 (2008).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"76664_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1128\/AAC.00786-06","volume":"51","author":"C Kusuma","year":"2007","unstructured":"Kusuma, C., Jadanova, A., Chanturiya, T. & Kokai-Kun, J. F. Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo. Antimicrob. Agents Chemother. 51, 475\u2013482 (2007).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76664_CR16","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1128\/AAC.45.5.1431-1437.2001","volume":"45","author":"MW Climo","year":"2001","unstructured":"Climo, M. W., Ehlert, K. & Archer, G. L. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45, 1431\u20131437 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76664_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1128\/jb.179.1.9-16.1997","volume":"179","author":"AM Stranden","year":"1997","unstructured":"Stranden, A. M., Ehlert, K., Labischinski, H. & Berger-B\u00e4chi, B. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J. Bacteriol. 179, 9\u201316 (1997).","journal-title":"J. Bacteriol."},{"key":"76664_CR18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1128\/AAC.42.4.936","volume":"42","author":"B Ling","year":"1998","unstructured":"Ling, B. & Berger-B\u00e4chi, B. Increased overall antibiotic susceptibility in Staphylococcus aureus femABnull mutants. Antimicrob. Agents Chemother. 42, 936\u2013938 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76664_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3390\/ph3041139","volume":"3","author":"MD Bastos","year":"2010","unstructured":"Bastos, M. D., Coutinho, B. G. & Coelho, M. L. Lysostaphin: a staphylococcal bacteriolysin with potential clinical applications. Pharmaceuticals 3, 1139\u20131161 (2010).","journal-title":"Pharmaceuticals"},{"key":"76664_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJM197408012910507","volume":"14","author":"FR Stark","year":"1974","unstructured":"Stark, F. R., Thornsvard, C., Flannery, E. P. & Artenstein, M. S. Systemic lysostaphin in man-apparent antimicrobial activity in a neutropenic patient. N. Engl. J. Med. 14, 239\u2013240 (1974).","journal-title":"N. Engl. J. Med."},{"key":"76664_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/iai.11.2.309-312.1975","volume":"11","author":"EF Harrison","year":"1975","unstructured":"Harrison, E. F., Fuquay, M. E. & Zygmunt, W. A. Antigenic response to topically applied proteins. Infect. Immun. 11, 309\u2013312 (1975).","journal-title":"Infect. Immun."},{"key":"76664_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0165-2427(92)90017-K","volume":"31","author":"MJ Daley","year":"1992","unstructured":"Daley, M. J. & Oldham, E. R. Lysostaphin: immunogenicity of locally administered recombinant protein used in mastitis therapy. Vet. Immunol. Immunopathol. 31, 301\u2013312 (1992).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"76664_CR23","doi-asserted-by":"publisher","first-page":"11441","DOI":"10.1021\/acs.jafc.2c03459","volume":"70","author":"J Zha","year":"2022","unstructured":"Zha, J., Li, J., Su, Z., Akimbekov, N. & Wu, X. Lysostaphin: engineering and potentiation toward better applications. J. Agric. Food Chem. 70, 11441\u201311457 (2022).","journal-title":"J. Agric. Food Chem."},{"key":"76664_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.chembiol.2015.04.017","volume":"22","author":"H Zhao","year":"2015","unstructured":"Zhao, H. et al. Depletion of T cell epitopes in lysostaphin mitigates anti-drug antibody response and enhances antibacterial efficacy in vivo. Chem. Biol. 22, 629\u2013639 (2015).","journal-title":"Chem. Biol."},{"key":"76664_CR25","doi-asserted-by":"publisher","first-page":"15021","DOI":"10.1038\/mtm.2015.21","volume":"2","author":"K Blazanovic","year":"2015","unstructured":"Blazanovic, K. et al. Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance. Mol. Ther. Methods Clin. Dev. 2, 15021 (2015).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"76664_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-1-4939-6637-0_20","volume":"1529","author":"Y Choi","year":"2017","unstructured":"Choi, Y., Verma, D., Griswold, K. E. & Bailey-Kellogg, C. EpiSweep: computationally driven reengineering of therapeutic proteins to reduce immunogenicity while maintaining function. Methods Mol. Biol. 1529, 375\u2013398 (2017).","journal-title":"Methods Mol. Biol."},{"key":"76664_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb9011","volume":"6","author":"H Zhao","year":"2020","unstructured":"Zhao, H. et al. Globally deimmunized lysostaphin evades human immune surveillance and enables highly efficacious repeat dosing. Sci. Adv. 6, eabb9011 (2020).","journal-title":"Sci. Adv."},{"key":"76664_CR28","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1128\/AAC.01056-10","volume":"55","author":"R Satishkumar","year":"2011","unstructured":"Satishkumar, R. et al. Evaluation of the antimicrobial activity of lysostaphin-coated hernia repair meshes. Antimicrob. Agents Chemother. 55, 4379\u20134385 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76664_CR29","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jss.2011.04.014","volume":"171","author":"I Belyansky","year":"2011","unstructured":"Belyansky, I. et al. The addition of lysostaphin dramatically improves survival, protects porcine biomesh from infection, and improves graft tensile shear strength. J. Surg. Res. 171, 409\u2013415 (2011).","journal-title":"J. Surg. Res."},{"key":"76664_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115940","volume":"9","author":"CD Windolf","year":"2014","unstructured":"Windolf, C. D., L\u00f6gters, T., Scholz, M., Windolf, J. & Floh\u00e9, S. Lysostaphin-coated titan-implants preventing localized osteitis by Staphylococcus aureus in a mouse model. PLoS ONE 9, e115940 (2014).","journal-title":"PLoS ONE"},{"key":"76664_CR31","doi-asserted-by":"publisher","first-page":"e113797","DOI":"10.1371\/journal.pone.0113797","volume":"9","author":"B Xue","year":"2014","unstructured":"Xue, B. et al. A novel controlled-release system for antibacterial enzyme lysostaphin delivery using hydroxyapatite\/ chitosan composite bone cement. PLoS ONE 9, e113797 (2014).","journal-title":"PLoS ONE"},{"key":"76664_CR32","doi-asserted-by":"publisher","first-page":"E4960","DOI":"10.1073\/pnas.1801013115","volume":"115","author":"CT Johnson","year":"2018","unstructured":"Johnson, C. T. et al. Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by Staphylococcus aureus and supports fracture healing. Proc. Natl. Acad. Sci. USA 115, E4960\u2013E4969 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76664_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw1228","volume":"5","author":"CT Johnson","year":"2019","unstructured":"Johnson, C. T. et al. Lysostaphin and BMP-2 co-delivery reduces S. aureus infection and regenerates critical-sized segmental bone defects. Sci. Adv. 5, eaaw1228 (2019). No.","journal-title":"Sci. Adv."},{"key":"76664_CR34","doi-asserted-by":"publisher","first-page":"16625","DOI":"10.1021\/acsnano.1c06460","volume":"15","author":"X Lin","year":"2021","unstructured":"Lin, X. et al. Lung-targeting lysostaphin microspheres for methicillin-resistant Staphylococcus aureus pneumonia treatment and prevention. ACS Nano 15, 16625\u201316641 (2021).","journal-title":"ACS Nano"},{"key":"76664_CR35","doi-asserted-by":"publisher","first-page":"6703","DOI":"10.1021\/acsami.4c18004","volume":"17","author":"J Liu","year":"2025","unstructured":"Liu, J. et al. Modular engineering of lysostaphin with significantly improved stability and bioavailability for treating MRSA infections. Acs. Appl. Mater. Interfaces 17, 6703\u20136715 (2025).","journal-title":"Acs. Appl. Mater. Interfaces"},{"key":"76664_CR36","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jconrel.2020.11.045","volume":"10","author":"X Yang","year":"2021","unstructured":"Yang, X. et al. Eradicating intracellular MRSA via targeted delivery of lysostaphin and vancomycin with mannose-modified exosomes. J. Control. Release 10, 454\u2013467 (2021).","journal-title":"J. Control. Release"},{"key":"76664_CR37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1128\/AAC.47.2.554-558.2003","volume":"47","author":"S Walsh","year":"2003","unstructured":"Walsh, S., Shah, A. & Mond, J. Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol. Antimicrob. Agents Chemother. 47, 554\u2013558 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76664_CR38","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1021\/ja00011a057","volume":"113","author":"DW Urry","year":"1991","unstructured":"Urry, D. W. et al. Temperature of polypeptide inverse temperature transition depends on mean residue hydrophobicity. J. Am. Chem. Soc. 113, 4346\u20134348 (1991).","journal-title":"J. Am. Chem. Soc."},{"key":"76664_CR39","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jconrel.2014.06.028","volume":"190","author":"SR MacEwan","year":"2014","unstructured":"MacEwan, S. R. & Chilkoti, A. Applications of elastin-like polypeptides in drug delivery. J. Control. Release 190, 314\u2013330 (2014).","journal-title":"J. Control. Release"},{"key":"76664_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.addr.2015.12.007","volume":"97","author":"JC Rodr\u00edguez-Cabello","year":"2016","unstructured":"Rodr\u00edguez-Cabello, J. C., Arias, F. J., Rodrigo, M. A. & Girotti, A. Elastin-like polypeptides in drug delivery. Adv. Drug Deliv. Rev. 97, 85\u2013100 (2016).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"76664_CR41","doi-asserted-by":"publisher","first-page":"114541","DOI":"10.1016\/j.addr.2022.114541","volume":"190","author":"L Gong","year":"2022","unstructured":"Gong, L., Yang, Z., Zhang, F. & Gao, W. Cytokine conjugates to elastin-like polypeptides. Adv. Drug Deliv. Rev. 190, 114541 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"76664_CR42","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1002\/adma.201503440","volume":"27","author":"J Hu","year":"2015","unstructured":"Hu, J., Wang, G., Liu, X. & Gao, W. Enhancing pharmacokinetics, tumor accumulation, and antitumor efficacy by elastin-like polypeptide fusion of interferon alpha. Adv. Mater. 27, 7320\u20137324 (2015).","journal-title":"Adv. Mater."},{"key":"76664_CR43","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1039\/C8BM01096J","volume":"7","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. One-month zero-order sustained release and tumor eradication after a single subcutaneous injection of interferon alpha fused with a body-temperature-responsive polypeptide. Biomater. Sci. 7, 104\u2013112 (2019).","journal-title":"Biomater. Sci."},{"key":"76664_CR44","first-page":"1","volume":"10","author":"S Zhang","year":"2023","unstructured":"Zhang, S., Sun, Y., Zhang, L., Zhang, F. & Gao, W. Thermoresponsive polypeptide fused L-asparaginase with mitigated immunogenicity and enhanced efficacy in treating hematologic malignancies. Adv. Sci. 10, 1\u201313 (2023).","journal-title":"Adv. Sci."},{"key":"76664_CR45","first-page":"1","volume":"13","author":"Z Yang","year":"2024","unstructured":"Yang, Z. et al. A superlong-acting growth hormone-polypeptide fusion for growth hormone deficiency treatment. Adv. Healthc. Mater. 13, 1\u201311 (2024).","journal-title":"Adv. Healthc. Mater."},{"key":"76664_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120447","volume":"264","author":"P Liang","year":"2021","unstructured":"Liang, P. et al. Spatiotemporal combination of thermosensitive polypeptide fused interferon and temozolomide for post-surgical glioblastoma immunochemotherapy. Biomaterials 264, 120447 (2021).","journal-title":"Biomaterials"},{"key":"76664_CR47","doi-asserted-by":"publisher","first-page":"2400098","DOI":"10.1002\/adtp.202400098","volume":"7","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Synergic chemoimmunotherapy of cervical cancer by combining cisplatin with thermosensitive polypeptide fused interferon alpha. Adv. Ther. 7, 2400098 (2024).","journal-title":"Adv. Ther."},{"key":"76664_CR48","doi-asserted-by":"publisher","first-page":"1900586","DOI":"10.1002\/advs.201900586","volume":"6","author":"Z Wang","year":"2019","unstructured":"Wang, Z. et al. Thermoresponsive and protease-cleavable interferon-polypeptide conjugates with spatiotemporally programmed two-step release kinetics for tumor therapy. Adv. Sci. 6, 1900586 (2019).","journal-title":"Adv. Sci."},{"key":"76664_CR49","doi-asserted-by":"publisher","first-page":"122740","DOI":"10.1016\/j.biomaterials.2024.122740","volume":"312","author":"S Zhang","year":"2025","unstructured":"Zhang, S., Gong, L., Sun, Y., Zhang, F. & Gao, W. An ultra-long-acting L-asparaginase synergizes with an immune checkpoint inhibitor in starvation-immunotherapy of metastatic solid tumors. Biomaterials 312, 122740 (2025).","journal-title":"Biomaterials"},{"key":"76664_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202501787","volume":"21","author":"L Gong","year":"2025","unstructured":"Gong, L. et al. Thermo-pH-sensitive polypeptides boost protein drug\u2019s tumor permeation and pharmacology. Small 21, 2501787 (2025).","journal-title":"Small"},{"key":"76664_CR51","doi-asserted-by":"publisher","first-page":"114002","DOI":"10.1016\/j.jconrel.2025.114002","volume":"385","author":"Q Yao","year":"2025","unstructured":"Yao, Q., Zhang, F., Yang, Z., Sun, Y. & Gao, W. A super-long-acting anti-PD-L1 nanobody fused to elastin-like polypeptide for triple-negative breast cancer immunotherapy. J. Control. Release 385, 114002 (2025).","journal-title":"J. Control. Release"},{"key":"76664_CR52","doi-asserted-by":"publisher","first-page":"50349","DOI":"10.1021\/acsami.5c11256","volume":"17","author":"F Zhang","year":"2025","unstructured":"Zhang, F. et al. Trichosanthin fused to thermo-pH-sensitive polypeptides for synergistic cancer immunotherapy. ACS Appl. Mater. Interfaces 17, 50349\u201350363 (2025).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"76664_CR53","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.jconrel.2020.08.065","volume":"328","author":"Z Wang","year":"2020","unstructured":"Wang, Z., Guo, J., Liu, X., Sun, J. & Gao, W. Temperature-triggered micellization of interferon alpha-diblock copolypeptide conjugate with enhanced stability and pharmacology. J. Control. Release 328, 444\u2013453 (2020).","journal-title":"J. Control. Release"},{"key":"76664_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41589-019-0393-4","volume":"16","author":"LS Gonzalez-Delgado","year":"2020","unstructured":"Gonzalez-Delgado, L. S. et al. Two-site recognition of Staphylococcus aureus peptidoglycan by lysostaphin SH3b. Nat. Chem. Biol. 16, 24\u201330 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"76664_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55227-5","volume":"16","author":"Y Xiao","year":"2025","unstructured":"Xiao, Y. et al. A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy. Nat. Commun. 16, 138 (2025).","journal-title":"Nat. Commun."},{"key":"76664_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202506337","volume":"12","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Mitochondrial transplantation augments the reparative capacity of macrophages following myocardial injury. Adv. Sci. 12, e06337 (2025).","journal-title":"Adv. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76664-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76664-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76664-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:04:13Z","timestamp":1790121853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76664-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76664"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76664-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"4 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10108"}}